Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26th, at Lotte New York...

Key Takeaway: NEW BRUNSWICK, N.J. , Feb. 12, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 9 th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26 th , at Lotte New York Palace, NY. Ashley McEvoy , Executive Vice President, Worldwide Chairman, M

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Feb. 12, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 9 th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26 th , at Lotte New York Palace, NY. Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 2:00 p.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Last updated: Feb 12, 2020